Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app reads lips to give voice to ICU patients

NCT ID NCT06027866

Symptom relief Sponsor: Queen's University, Belfast Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a smartphone app called SRAVI that reads lip movements and turns them into words on a screen. It was used by 31 adult patients in acute or critical care who had a tracheostomy and could not speak. The goal was to see if the app could help them communicate better with staff and family.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SRAVI (Speech Recognition Application for the Voice Impaired) – a lip-reading app for smartphones or tablets
What this could lead to
If it works, this app could give a voice to patients who cannot speak due to a tracheostomy, reducing distress and improving care.
What could go wrong
This was a small, completed observational study (31 participants) testing feasibility, not a large trial. The app may not work well for all patients or in all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

31 people

The number who actually took part.

Started

Jan 2023

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Acute/critical care tracheostomy patients

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and over * Patients who acquire a tracheostomy in acute/critical care * Patients can move lips in a way that articulates words * Able to communicate in English (a current requirement of the technology) Exclusion Criteria: -Patient declined consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute/critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Communication communication disorder Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute/critical illness Communication Tracheostomy

Contacts and locations

Locations

  • Wellcome-Wolfson Institute for Experimental Medicine Queen's University Belfast

    Belfast, Northern Ireland, BT9 7BL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.